Institute of Cell and Molecular Pathology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.
Haematologica. 2010 May;95(5):841-4. doi: 10.3324/haematol.2009.015503. Epub 2009 Dec 16.
Biallelic mutations of mismatch repair genes cause constitutional mismatch repair deficiency associated with an increased risk for childhood leukemia/lymphoma. We report on a case with constitutional mismatch repair deficiency caused by a novel MSH6 mutation leading to a T-cell lymphoma and colonic adenocarcinoma at six and 13 years of age, respectively. A review of the literature on hematologic malignancies in constitutional mismatch repair deficiency showed that in almost half of the 47 known constitutional mismatch repair deficiency families, at least one individual is affected by a hematologic malignancy, predominantly T-cell lymphomas. However, diagnosing constitutional mismatch repair deficiency may be difficult when the first child is affected by leukemia/lymphoma, but identification of the causative germline mutation is of vital importance: (i) to identify relatives at risk and exclude an increased risk in non-mutation carriers; (ii) to prevent hematopoietic stem cell transplantation from sibling donors also carrying a biallelic germline mutation; and (iii) to implement effective surveillance programs for mutation carriers, that may reduce constitutional mismatch repair deficiency-associated mortality.
双等位基因突变导致错配修复基因缺陷与儿童白血病/淋巴瘤风险增加相关。我们报告了一例由新型 MSH6 突变引起的错配修复基因缺陷导致的 T 细胞淋巴瘤和结肠腺癌,分别在 6 岁和 13 岁时发病。对文献中错配修复基因缺陷相关血液系统恶性肿瘤的回顾显示,在已知的 47 个错配修复基因缺陷家族中,几乎有一半的家族至少有一个个体受到血液系统恶性肿瘤的影响,主要是 T 细胞淋巴瘤。然而,当第一个孩子受到白血病/淋巴瘤的影响时,可能难以诊断错配修复基因缺陷,但确定致病的种系突变至关重要:(i)识别有风险的亲属,并排除非突变携带者的风险增加;(ii)防止也携带双等位基因突变的同胞供者进行造血干细胞移植;(iii)对突变携带者实施有效的监测计划,这可能会降低错配修复基因缺陷相关的死亡率。